What does the evidence say about Pistachio Blood Pressure Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Pistachio Blood Pressure Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - A greater capacity for butyrate production is linked to improved postprandial insulin response [] and reductions in glycated hemoglobin (HbA1c) [], suggesting that pistachios may benefit those with impaired glucose metabolism. [Riley Terrence M (2025); evidence level 2] - Although pistachios may have glucomodulatory effects among those with prediabetes, type 2 diabetes mellitus (T2DM), and cardiovascular disease risk factors [,], limited work has described the microbial response to pistachio consumption in these populations. [Riley Terrence M (2025); evidence level 2] - A study among adults with prediabetes showed that daily pistachio consumption (57 g/d) reduced urine concentrations of hippurate, a microbiota-related metabolite positively associated with insulin resistance and T2DM risk []. [Riley Terrence M (2025); evidence level 2] - 1 2 3 4 5 6 The human gut microbiota is shaped predominantly by nongenetic factors, of which diet is a key short- and long-term regulator []. [Riley Terrence M (2025); evidence level 2] - The Global Burden of Disease Study includes data from almost 200 countries and cites low nut and seed consumption among the leading risk factors for chronic disease []. [Tindall Alyssa (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.